Maraqa Bayan, Lataifeh Isam, Otay Lian, Badran Osama, Qutaiba Nouri Yasar, Issam Ibtihal, Al Hussaini Maysa
Department of Pathology King Hussein Cancer Center, (KHCC) Amman, Jordan. Email:
Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3117-3121. doi: 10.22034/APJCP.2017.18.11.3117.
Background and aims: Cervical cancer is the fourth most common cancer in women worldwide and the 13th in Jordan. The cervical smear (Pap smear) is a simple approach to detect pre-cancerous cervical lesions. The aim of this study was to evaluate the prevalence of abnormal cervical smears in women seen at the Early Detection/Community Outreach clinic of King Hussein Cancer Center (KHCC). Materials and Methods: In this retrospective study, reports of routine cervical Pap smears performed in the pathology department at KHCC from January 2007 to December 2016, were reviewed. During this period, a total of 5,529 routine smears were assessed for epithelial abnormalities and histopathological grading. Results: A total of 210 (3.8%) abnormal Pap smears were found, with atypical squamous cell of undetermined significance (ASC-US) reported in 110 (52.4%) cases, atypical glandular cells of undermined significance (AGUS) in 58 (27.6%), low grade squamous intra-epithelial lesion (LSIL) in 27 (12.9%) and high grade intra-epithelial lesion (HSIL) in 13 (6.2%). Only single cases of ASC-H and squamous cell carcinoma were reported. The available biopsies showed benign findings in 70.1% of cases, low grade squamous intraepithelial lesions in 11.5% and high grade squamous intraepithelial lesions in 18.4%. Conclusions: The low epithelial cell abnormality (EPCA) prevalence illustrated in this study argues against introduction of population-based HPV testing and vaccination. It calls for a more cost-effective measures in a country with limited resources, where a more widely available Pap-smear testing might suffice.
宫颈癌是全球女性中第四大常见癌症,在约旦位列第13位。宫颈涂片检查(巴氏涂片)是检测宫颈癌前病变的一种简单方法。本研究的目的是评估在侯赛因国王癌症中心(KHCC)早期检测/社区外展诊所就诊的女性中异常宫颈涂片的患病率。
在这项回顾性研究中,对2007年1月至2016年12月在KHCC病理科进行的常规宫颈巴氏涂片报告进行了审查。在此期间,共评估了5529份常规涂片的上皮异常情况和组织病理学分级。
共发现210份(3.8%)异常巴氏涂片,其中意义不明确的非典型鳞状细胞(ASC-US)报告了110例(52.4%),意义不明确的非典型腺细胞(AGUS)58例(27.6%),低级别鳞状上皮内病变(LSIL)27例(12.9%),高级别上皮内病变(HSIL)13例(6.2%)。仅报告了单例ASC-H和鳞状细胞癌。现有活检结果显示,70.1%的病例为良性,11.5%为低级别鳞状上皮内病变,18.4%为高级别鳞状上皮内病变。
本研究中显示的低上皮细胞异常(EPCA)患病率表明不支持引入基于人群的HPV检测和疫苗接种。在一个资源有限的国家,这需要采取更具成本效益的措施,在这种情况下,更广泛可用的巴氏涂片检测可能就足够了。